Computational study of coagulation factor VIIa's affinity for phospholipid membranes

Olivier Taboureau1, Ole Hvilsted Olsen

  • 1Haemostasis Biochemistry, Novo Nordisk A/S, Novo Nordisk Park, Building G8.2.90, 2760 Måløv, Denmark.

Summary

Specific mutations in the gamma-carboxyglutamic acid-rich domain of coagulation factor VIIa (FVIIa) enhance its binding to phospholipid membranes, crucial for blood coagulation initiation. These changes improve membrane interaction by altering protein structure and accessibility.